Innovation in Development of Dermatologic Drugs Approved by the FDA
Dermatologic drug development in the US has remained disproportionately low compared with other therapeutic classes due to lower revenue potential and benefit-to-risk ratios. [...]
Copyright © 2024 | DLIT.CO